Suppr超能文献

外侧下蒂皮瓣在 Draf IIb 治疗复发性额窦疾病中的价值:一项前瞻性研究。

Value of a lateral inferior pedicle flap in Draf IIb for recurrent frontal sinus diseases: a prospective study.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China.

出版信息

Eur Arch Otorhinolaryngol. 2022 Oct;279(10):4935-4942. doi: 10.1007/s00405-022-07302-0. Epub 2022 Feb 26.

Abstract

PURPOSE

The Draf IIb procedure allows the widest unilateral access to the frontal sinus in a minimally invasive fashion, with efficiency and safety comparable to the Draf III. However, this technique is still associated with a high postoperative stenosis rate. The exposure of drilled bone induces osteitis predisposing to scarring and neo-osteogenesis causing ostium restenosis. We developed a novel lateral inferior pedicle flap (LIPF) to cover the exposed bone and prevent restenosis during Draf IIb. We aimed to describe our technique.

METHODS

Adult patients requiring a Draf IIb for unilateral recurrent frontal sinus disease were prospectively enrolled. A LIPF technique was systematically performed. Demographics and complications were recorded. The primary outcome measure was neo-ostium patency at 12 months. In patients with chronic rhinosinusitis (CRS), the clinical control rate was evaluated at 12 months.

RESULTS

59 patients underwent the Draf IIb with LIPF technique from 2013 to 2021. 49 patients (20 women/29 men, median age of 48.0 years) completed at least 12 months of follow-up (median 41.0 months, range 12-100 months). Indications included recalcitrant CRS (n = 32), inverted papilloma (n = 9) and frontal mucocele (n = 8). Overall, the neo-ostium remained patent at 12 months in all patients, and the clinical control rate of 32 patients with recalcitrant CRS at 12 months was 100%. No main complications were recorded.

CONCLUSION

The LIPF technique was associated with a high rate of success for a Draf IIb.

摘要

目的

Draf IIb 手术允许以最小的侵入性方式最大限度地单侧进入额窦,其效率和安全性可与 Draf III 相媲美。然而,这种技术仍然与较高的术后狭窄率相关。钻孔骨的暴露会引发骨炎,从而容易发生瘢痕形成和新骨生成,导致窦口再狭窄。我们开发了一种新的外侧下蒂皮瓣(LIPF)来覆盖暴露的骨,以防止 Draf IIb 术后再狭窄。我们旨在描述我们的技术。

方法

前瞻性招募需要单侧复发性额窦疾病进行 Draf IIb 的成年患者。系统地进行 LIPF 技术。记录人口统计学和并发症。主要观察指标是 12 个月时新窦口通畅率。在慢性鼻-鼻窦炎(CRS)患者中,评估 12 个月时的临床控制率。

结果

2013 年至 2021 年,59 例患者接受了 Draf IIb 联合 LIPF 技术。49 例患者(20 例女性/29 例男性,中位年龄 48.0 岁)完成了至少 12 个月的随访(中位随访时间 41.0 个月,范围 12-100 个月)。适应证包括难治性 CRS(n=32)、内翻性乳头状瘤(n=9)和额窦黏液囊肿(n=8)。总的来说,所有患者在 12 个月时新窦口保持通畅,32 例难治性 CRS 患者在 12 个月时的临床控制率为 100%。未记录到主要并发症。

结论

LIPF 技术与 Draf IIb 的高成功率相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/130c/9474523/6409300c3660/405_2022_7302_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验